The role of hormonal therapy in patients with uterine carcinoma.

Vinklerová, P; Minár, L; Felsinger, M; Anton, M; Ventruba, P; Bednaríková, M; Hausnerová, J; Jandáková, E; Cíhalová, M; Weinberger, V

Vinklerová, P; Minár, L; Felsinger, M; Anton, M; Ventruba, P; Bednaríková, M; Hausnerová, J; Jandáková, E; Cíhalová, M; Weinberger, V.

Ceska Gynekol ; 83(4): 263-270, 2018.

Article in En | MEDLINE | ID: mdl-30441956

Subject(s)

Antineoplastic Agents, Hormonal/therapeutic use; Uterine Neoplasms/drug therapy; Aged, 80 and over; Female; Humans; Medroxyprogesterone Acetate/therapeutic use; Megestrol Acetate/therapeutic use; Neoplasm Recurrence, Local/pathology; Retrospective Studies; Uterine Neoplasms/mortality

Key words

endometrial carcinoma; hormone therapy; medroxyprogesterone-acetate; megestrol-acetate; palliative therapy fertility-sparing treatment.

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Uterine Neoplasms / Antineoplastic Agents, Hormonal Type of study: Observational_studies Limits: Aged80 / Female / Humans Language: En Journal: Ceska Gynekol Year: 2018 Document type: Article

Search on Google

XML

PubMed Links